New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
09:25 EDTINSM, INSMLeerink biotech analyst holds an analyst/industry conference call
Biotech Analyst Schwartz discusses the regulatory outlook and market opportunity for Insmed's Arikayce (inhaled lipsomal amikacin), for non-tuberculosis mycobacteria lung infections, on an Analyst/Industry conference call to be held on June 19 at 10 am.
News For INSM From The Last 14 Days
Check below for free stories on INSM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for INSM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use